RecruitingNCT03973268
Official study titleThe Mechanism of Action Underlying Ketamine's Antidepressant Effects: An Investigation of the AMPA Throughput Theory in Patients With Treatment-Resistant Major Depression
In BethesdaDepressionMedication studyAges 18–70
- Countries
- United States
- Sponsor
- National Institute of Mental Health (NIMH) (Government agency)
RecruitingNCT07328373
Official study titleNeurobiological and Genomic Predictors of Relapse After Discontinuation of Antidepressant Treatment in Major Depressive Disorder: An Observational Prospective Study
In IstanbulDepressionObservational studyAges 18–65
- Countries
- Türkiye
- Sponsor
- Mehmet Kemal Arikan
RecruitingNCT06467474
Official study titlePsychoeducation for Major Depressive Disorder: Development and Evaluation of Effectiveness
In São PauloDepressionMedication studyAges 18–59
- Countries
- Brazil
- Sponsor
- Ricardo Alberto Moreno, M.D., Ph.D.
Not Yet RecruitingACTRN12624001343594
What is this study about?This study evaluates the safety and effectiveness of psychotherapy for people with depression.
This study isn't recruiting yet.
In AustraliaDepressionInterventional studyAges 18+
- Countries
- Australia
- Sponsor
- GoodMind Therapeutics
RecruitingNCT04041479
Official study titleEfficacy of Biomarker-guided rTMS for Treatment Resistant Depression
Multiple locations, including StanfordDepressionDevice studyAges 22–65
- Countries
- United States
- Sponsor
- Weill Medical College of Cornell University
RecruitingNCT03537794
In TorontoDepressionObservational studyAges 25–65
- Countries
- Canada
- Sponsor
- Unity Health Toronto
RecruitingNCT06732089
Official study titleDetermining the Feasibility of Digital Interventions for Adults with Treatment-Resistant Depression
In TorontoDepressionObservational studyAges 18+
- Countries
- Canada
- Sponsor
- Unity Health Toronto
RecruitingNCT06480201
In HoustonDepressionMedication studyAges 21–45
- Countries
- United States
- Sponsor
- Texas A&M University
RecruitingNCT06938841
Official study titleMaintaining the Acute Therapeutic Effect of rTMS in Treatment-Resistant Depression (Maitr-De)
Multiple locations, including San DiegoDepressionDevice studyAges 18–80
- Countries
- United States, Australia
- Sponsor
- University of California, San Diego
RecruitingNCT06130371
In TübingenDepressionObservational studyAges 18–40
- Countries
- Germany
- Sponsor
- University Hospital Tuebingen
RecruitingNCT06163625
In TorontoDepressionStudy assessmentsAges 18–65
- Countries
- Canada
- Sponsor
- Unity Health Toronto
Not Yet RecruitingNCT07528157
Official study titleEarly TMS-EEG Potentials as Biomarkers for Personalized Neuromodulation in Treatment-Resistant Depression (R61 Phase)
This study isn't recruiting yet.
In StanfordDepressionDevice studyAges 18–65
- Countries
- United States
- Sponsor
- Stanford University
Data coveragePublic registry coverage is progressing
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.
Get research updates
